-
Inebilizumab, sold
under the
brand name Uplizna, is a
medication for the
treatment of
neuromyelitis optica spectrum disorder (NMOSD) in adults. Inebilizumab...
-
Multiple sclerosis,
various autoimmune disorders Medication Eculizumab,
inebilizumab, satralizumab, rituximab, methylprednisolone, azathioprine, cellCept...
- (teprotumumab)
Tezspire (tezepelumab-ekko)
Tavneos (avacopan)
Uplizna (
inebilizumab)
Vectibix (panitumumab for
colon cancer) (FDA
approved 2006)
Xgeva (denosumab)...
-
Alemtuzumab L04AG07
Begelomab L04AG08
Ocrelizumab L04AG09
Emapalumab L04AG10
Inebilizumab L04AG11
Anifrolumab L04AG12
Ofatumumab L04AG13
Teprotumumab L04AG14 Ublituximab...
- from the
original on 19
March 2020.
Retrieved 14 June 2019. "Uplizna-
inebilizumab injection". DailyMed. 8 July 2019.
Archived from the
original on 13 June...
- Efalizumab‡
Epratuzumab Erlizumab Etrolizumab†
Fontolizumab Frexalimab†
Inebilizumab Itolizumab Lampalizumab†
Letolizumab Ligelizumab†
Lulizumab pegol Mepolizumab...
- Efalizumab‡
Epratuzumab Erlizumab Etrolizumab†
Fontolizumab Frexalimab†
Inebilizumab Itolizumab Lampalizumab†
Letolizumab Ligelizumab†
Lulizumab pegol Mepolizumab...
-
carcinoma Atezolizumab Genentech metastatic hepatocellular carcinoma Inebilizumab Viela Bio
neuromyelitis optica spectrum disorder Fostemsavir Viiv Healthcare...
-
Anifrolumab Atorolimumab Begelomab Cedelizumab Emapalumab Fontolizumab Inebilizumab Maslimomab Morolimumab Ofatumumab Pexelizumab Reslizumab Rovelizumab...
- Antigenomycs, Inc. The drug
Tedder developed at
Cellective Therapeutics,
inebilizumab, has now been
approved for
NMSOD use in the
United States under the clinical...
